Drug · DIN 02420600
DONEPEZIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 8, 2025; first marketed February 11, 2014.
- Drug Identification Number (DIN)
- 02420600
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Donepezil N06DA02
- Class
- Human
- Record last updated
- August 26, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DONEPEZIL HYDROCHLORIDE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 5, 2024: NOC 34506Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
- October 5, 2021: NOC 26798Abbreviated New Drug Submission (ANDS)
- December 8, 2017: NOC 20140Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- February 6, 2014: NOC 15208Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named DONEPEZIL
- DIN 02420597 · Marketed
- DIN 02426846 · Marketed
- DIN 02426854 · Marketed
- DIN 02475278 · Marketed
- DIN 02421453 · Cancelled Pre Market
- DIN 02421461 · Cancelled Pre Market
- DIN 02475286 · Dormant